Ticker

No recent analyst price targets found for MASS.

Latest News for MASS

Masivo Silver Corp. Launches Phase I Drill Program at Cerro Colorado Project, Sonora, Mexico

Vancouver, British Columbia--(Newsfile Corp. - February 26, 2026) - Masivo Silver Corp. (TSXV: MASS) (OTC Pink: GNYPF) (FSE: R74) ("Masivo" or the "Company") is pleased to announce that the Company's Phase I diamond drill program has begun at its Cerro Colorado Project in Sonora, Mexico. The initial phase of the program consists of approximately eight (8) diamond drill holes totaling an estimated 1,500 to 2,000…

Newsfile Corp • Feb 26, 2026
908 Devices to Participate in Investor Conferences in March

BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced it will participate in the following investor conferences. TD Cowen 46th Annual Healthcare Conference, Boston, MA Fireside chat on Wednesday, March 4 at 9:10 a.m. Eastern Time Leerink…

Business Wire • Feb 24, 2026
908 Devices to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will report financial results for the fourth quarter and full year 2025 before market open on Tuesday, March 3, 2026. Company management will webcast a corresponding conference call beginning…

Business Wire • Feb 17, 2026
908 Devices Enhances MX908 Usability and Adds New Drug Targets

BURLINGTON, Mass.--(BUSINESS WIRE)-- #chemicalID--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces new capabilities for its handheld MX908 mass spectrometry device for trace chemical identification. These enhancements include an updated mission mode for hazardous vapor sampling and the addition of five priority drug targets, providing first responders with…

Business Wire • Feb 5, 2026
Analyzing 908 Devices (NASDAQ:MASS) & Vaso (OTCMKTS:VASO)

Vaso (OTCMKTS:VASO - Get Free Report) and 908 Devices (NASDAQ: MASS - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings and analyst recommendations. Profitability This table compares Vaso and 908 Devices'

Defense World • Jan 22, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for MASS.

No House trades found for MASS.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top